Vita Life Sciences Limited (VLS) Stock Statistics & Valuation Metrics

Vita Life Sciences Limited has a market cap or net worth of AUD 147.70M. The enterprise value is AUD 106.82M.

Market Cap

AUD 147.70M

Enterprise Value

AUD 106.82M

Vita Life Sciences Limited has 53,903,606 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

53,903,606

Owned by Insiders

2.19%

Owned by Institutions

―

Vita Life Sciences Limited’s return on equity (ROE) is 0.19 and return on invested capital (ROIC) is 18.05%.

Return on Equity (ROE)

0.19

Return on Assets (ROA)

0.13

Return on Invested Capital (ROIC)

18.05%

Return on Capital Employed (ROCE)

0.25

Revenue Per Employee

233.18K

Profits Per Employee

26.09K

Employee Count

400

Asset Turnover

1.13

Inventory Turnover

2.47

The current PE Ratio of Vita Life Sciences Limited is 13.70. Vita Life Sciences Limited’s PEG ratio is 0.78.

PE Ratio

13.70

PS Ratio

1.54

PB Ratio

2.67

Price to FCF

10.10

Price to Operating Cash Flow

10.08

PEG Ratio

0.78

In the last 12 months, Vita Life Sciences Limited had revenue of 93.27M and earned 10.44M in profits. Earnings per share was 0.19.

Revenue

93.27M

Gross Profit

56.03M

Operating Income

14.66M

Pretax Income

14.43M

Net Income

10.44M

EBITDA

15.66M

Earnings Per Share (EPS)

0.19

In the last 12 months, operating cash flow was 14.78M and capital expenditures -157,000, giving a free cash flow of 14.63M billion.

Operating Cash Flow

14.78M

Free Cash Flow

14.63M

Free Cash Flow per Share

0.27

Vita Life Sciences Limited pays an annual dividend of AUD 0.05, resulting in a dividend yield of 5.29%

Dividend Per Share

AUD 0.05

Dividend Yield

5.29%

Payout Ratio

66.27%

Free Cash Flow Yield

9.90%

Earnings Yield

7.49%

Beta

0.05

52-Week Price Change

14.17%

50-Day Moving Average

2.76

200-Day Moving Average

2.53

Relative Strength Index (RSI)

44.10

Average Volume (3m)

16.75K

Vita Life Sciences Limited upcoming earnings date is Feb 25, 2027, TBA (Not Confirmed).

Last Earnings Date

Aug 17, 2026

Next Earnings Date

Feb 25, 2027

Ex-Dividend Date

Sep 19, 2025

Vita Life Sciences Limited as a current ratio of 2.72, with Debt / Equity ratio of 4.25%

Current Ratio

2.72

Quick Ratio

2.10

Debt to Market Cap

0.00

Net Debt to EBITDA

-2.12

Interest Coverage Ratio

41.52

In the past 12 months, Vita Life Sciences Limited has paid 4.00M in taxes.

Income Tax

4.00M

Effective Tax Rate

0.28

Vita Life Sciences Limited EV to EBITDA ratio is 7.37, with an EV/FCF ratio of 7.94.

EV to Sales

1.21

EV to EBITDA

7.37

EV to Free Cash Flow

7.94

EV to Operating Cash Flow

7.86

Vita Life Sciences Limited has AUD 33.70M in cash and marketable securities with AUD 2.16M in debt, giving a net cash position of AUD 31.55M billion.

Cash & Marketable Securities

AUD 33.70M

Total Debt

AUD 2.16M

Net Cash

AUD 31.55M

Net Cash Per Share

AUD 0.59

Tangible Book Value Per Share

AUD 1.02

Gross margin is 62.81%, with operating margin of 16.75%, and net profit margin of 11.61%.

Gross Margin

62.81%

Operating Margin

16.75%

Pretax Margin

16.38%

Net Profit Margin

11.61%

EBITDA Margin

16.41%

EBIT Margin

15.83%

The average price target for Vita Life Sciences Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

12.19%

EPS Growth Forecast

22.36%

Smart Score

6

AI Score

74